Clinical Trials Browser

Phase 2 × Lung Neoplasms × Risedronic Acid × Clear all

NCT03861091 2023-07-27

Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

Phase 2 Completed

84 enrolled 13 charts

Lung Neoplasms